Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C (2013) Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 74(Suppl 1):35–49. https://doi.org/10.1038/pr.2013.205
Article PubMed PubMed Central Google Scholar
Hartnett ME, Penn JS (2012) Mechanisms and management of retinopathy of prematurity. N Engl J Med 367(26):2515–2526. https://doi.org/10.1056/NEJMra1208129
Article CAS PubMed PubMed Central Google Scholar
Terry TL (1944) Retrolental fibroplasia in the premature infant: V. Further studies on fibroplastic overgrowth of the persistent tunica vasculosa lentis. Trans Am Ophthalmol Soc 42:383–396
CAS PubMed PubMed Central Google Scholar
Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10(2):133–140. https://doi.org/10.1007/s10456-007-9066-0
Hellström A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382(9902):1445–1457. https://doi.org/10.1016/s0140-6736(13)60178-6
Article PubMed PubMed Central Google Scholar
Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB et al (2020) Incidence and early course of retinopathy of prematurity. Ophthalmology 127(4s):S84-s96. https://doi.org/10.1016/j.ophtha.2020.01.034
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A et al (2021) International Classification of Retinopathy of Prematurity Third Edition. Ophthalmology 128(10):e51–e68. https://doi.org/10.1016/j.ophtha.2021.05.031
Nilsson M, Hellström A, Jacobson L (2016) Retinal sequelae in adults treated with cryotherapy for retinopathy of prematurity. Invest Ophthalmol Vis Sci 57(9):Oct550-5. https://doi.org/10.1167/iovs.15-18583
Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E et al (2021) Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 101018. https://doi.org/10.1016/j.preteyeres.2021.101018
Natarajan G, Shankaran S, Nolen TL, Sridhar A, Kennedy KA, Hintz SR et al (2019) Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 144(2). https://doi.org/10.1542/peds.2018-3537
Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN et al (2016) Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 137(4). https://doi.org/10.1542/peds.2015-3218
Selvam S, Kumar T, Fruttiger M (2018) Retinal vasculature development in health and disease. Prog Retin Eye Res 63:1–19. https://doi.org/10.1016/j.preteyeres.2017.11.001
Article CAS PubMed Google Scholar
Lawrence J, Xiao D, Xue Q, Rejali M, Yang S, Zhang L (2008) Prenatal nicotine exposure increases heart susceptibility to ischemia/reperfusion injury in adult offspring. J Pharmacol Exp Ther 324(1):331–341. https://doi.org/10.1124/jpet.107.132175
Article CAS PubMed Google Scholar
Webster WS, Abela D (2007) The effect of hypoxia in development. Birth Defects Res C Embryo Today 81(3):215–228. https://doi.org/10.1002/bdrc.20102
Article CAS PubMed Google Scholar
Castillo A, Sola A, Baquero H, Neira F, Alvis R, Deulofeut R et al (2008) Pulse oxygen saturation levels and arterial oxygen tension values in newborns receiving oxygen therapy in the neonatal intensive care unit: is 85% to 93% an acceptable range? Pediatrics 121(5):882–889. https://doi.org/10.1542/peds.2007-0117
Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM (2003) Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349(10):959–967. https://doi.org/10.1056/NEJMoa023080
Article CAS PubMed Google Scholar
Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA (2018) Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res 62:77–119. https://doi.org/10.1016/j.preteyeres.2017.09.002
Article CAS PubMed Google Scholar
Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27(4):331–371. https://doi.org/10.1016/j.preteyeres.2008.05.001
Article CAS PubMed PubMed Central Google Scholar
Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176(6):1248–1264. https://doi.org/10.1016/j.cell.2019.01.021
Article CAS PubMed PubMed Central Google Scholar
Liu CH, Wang Z, Sun Y, Chen J (2017) Animal models of ocular angiogenesis: from development to pathologies. Faseb J 31(11):4665–4681. https://doi.org/10.1096/fj.201700336R
Article CAS PubMed PubMed Central Google Scholar
Smith LE, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111
Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI et al (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4(11):1565–1573. https://doi.org/10.1038/nprot.2009.187
Article CAS PubMed PubMed Central Google Scholar
Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P et al (2010) Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Investig 120(9):3022–3032. https://doi.org/10.1172/jci42142
Article CAS PubMed PubMed Central Google Scholar
Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets–what are the challenges? Nat Rev Drug Discov 12(4):265–286. https://doi.org/10.1038/nrd3955
Article CAS PubMed PubMed Central Google Scholar
Parkinson FE, Damaraju VL, Graham K, Yao SY, Baldwin SA, Cass CE et al (2011) Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr Top Med Chem 11(8):948–972. https://doi.org/10.2174/156802611795347582
Article CAS PubMed Google Scholar
Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of adenosine receptors: the state of the art. Physiol Rev 98(3):1591–1625. https://doi.org/10.1152/physrev.00049.2017
Article CAS PubMed Google Scholar
Lutty GA, McLeod DS (2003) Retinal vascular development and oxygen-induced retinopathy: a role for adenosine. Prog Retin Eye Res 22(1):95–111. https://doi.org/10.1016/s1350-9462(02)00058-7
Article CAS PubMed Google Scholar
Xu Y, Wang Y, Yan S, Yang Q, Zhou Y, Zeng X et al (2017) Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. Nat Commun 8(1):943. https://doi.org/10.1038/s41467-017-00986-7
Article CAS PubMed PubMed Central ADS Google Scholar
Xu Y, Wang Y, Yan S, Zhou Y, Yang Q, Pan Y et al (2017) Intracellular adenosine regulates epigenetic programming in endothelial cells to promote angiogenesis. EMBO Mol Med 9(9):1263–78. https://doi.org/10.15252/emmm.201607066
Article CAS PubMed PubMed Central Google Scholar
Lutty GA, Merges C, McLeod DS (2000) 5’ nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 41(1):218–229
Taomoto M, McLeod DS, Merges C, Lutty GA (2000) Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 41(1):230–243
Zhang S, Li B, Tang L, Tong M, Jiang N, Gu X et al (2022) Disruption of CD73-derived and equilibrative nucleoside transporter 1-mediated adenosine signaling exacerbates oxygen-induced retinopathy. Am J Pathol. https://doi.org/10.1016/j.ajpath.2022.07.014
Article PubMed PubMed Central Google Scholar
Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, Geiger JD (2000) Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia. J Neurochem 75(2):795–802. https://doi.org/10.1046/j.1471-4159.2000.0750795.x
Article CAS PubMed Google Scholar
Chen JF, Zhang S, Zhou R, Lin Z, Cai X, Lin J et al (2017) Adenosine receptors and caffeine in retinopathy of prematurity. Mol Aspects Med 55:118–125. https://doi.org/10.1016/j.mam.2017.01.001
Article CAS PubMed PubMed Central Google Scholar
Zhang S, Li H, Li B, Zhong D, Gu X, Tang L et al (2015) Adenosine A1 receptors selectively modulate oxygen-induced retinopathy at the hyperoxic and hypoxic phases by distinct cellular mechanisms. Invest Ophthalmol Vis Sci 56(13):8108–8119. https://doi.org/10.1167/iovs.15-17202
Comments (0)